Home › Funds › Pacer Advisors, Inc. › BIIB

Pacer Advisors, Inc. position in BIIB

BIOGEN INC · Health Care

Pacer Advisors, Inc. reported holding 1,122,981 shares of BIIB (BIOGEN INC) in its Q2 2026 13F filing — a position valued at US$242.6M, representing 0.69% of its reported portfolio and ranking #37 among its reported holdings. Pacer Advisors, Inc. has disclosed BIIB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)1.12M sh
Reported value held$242.63M
Portfolio Weight0.69%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Pacer Advisors, Inc.'s BIIB position evolved

Pacer Advisors, Inc. first disclosed a stake in BIIB in Q3 2023 at 16,586 shares (US$4.3M). The position peaked in Q4 2024 at 2,667,531 shares, worth US$407.9M. Across 12 filings, Pacer Advisors, Inc. increased the stake 7 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,122,981 shares valued at US$242.6M — an increase of 462,573 shares quarter over quarter.. Notable position changes include a 13575% increase in Q4 2024 (shares fell 11% over the following quarter), a 96% trim in Q4 2025 (shares rose 4% over the following quarter), a 932% increase in Q1 2026 (shares rose 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 16.59K $4.26M New
Q4 2023 28.93K $7.49M Add
Q1 2024 16.92K $3.65M Reduce
Q2 2024 19.07K $4.42M Add
Q3 2024 19.51K $3.78M Add
Q4 2024 2.67M $407.92M Add
Q1 2025 1.35M $185.08M Reduce
Q2 2025 1.32M $165.78M Reduce
Q3 2025 1.45M $203.29M Add
Q4 2025 64.00K $67.29K Reduce
Q1 2026 660.41K $121.07M Add
Q2 2026 1.12M $242.63M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BIIB and 13F data

BIIB (BIOGEN INC) is a Health Care company. 22 other funds we track also report a position in BIIB — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$3.27B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BIIB

All BIIB fund holders →

FAQ

How long has Pacer Advisors, Inc. held BIIB?

Pacer Advisors, Inc. has disclosed BIIB holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Pacer Advisors, Inc.'s current position in BIIB?

As of Q2 2026, Pacer Advisors, Inc. holds 1.12M shares of BIIB (BIOGEN INC), valued at $242.63M, representing 0.69% of its reported portfolio and ranking #37.

Has Pacer Advisors, Inc. been buying or selling BIIB?

In the latest 13F filing (Q2 2026), Pacer Advisors, Inc. increased its position in BIIB. The position peaked in Q4 2024 at 2.67M shares.

Which other funds hold BIIB?

Other major institutional holders of BIIB include PRIMECAP MANAGEMENT CO/CA/, among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.